MP:0001265 | reduced body size | "smaller than average body weight, height and/or length of an organism compared to controls" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:23170] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0001596 | hypotension | "sustained low blood pressure at a level that is likely to result in cardiovascular disease and/or other pathological states" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0001745 | increased circulating corticosterone level | "greater than the normal concentration of this adrenocortical steroid; induces glycogen deposition and regulates sodium conservation and potassium secretion" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:cls, J:54931] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0001762 | polyuria | "increased volume of urine produced and excreted" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0002667 | decreased circulating aldosterone level | "decreased blood concentration of this hormone, secreted by the adrenal cortex, in the bloodstream; regulates sodium conservation and potassium secretion in the distal renal tubule" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0002842 | increased blood pressure | "increased tension of the blood within the systemic arteries" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0002988 | decreased urine osmolarity | "reduction in the concentration of ions in the urine compared to normal" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:83000] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0003020 | decreased circulating chloride level | "reduced concentration of chlorine salts in the circulation" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0003141 | cardiac fibrosis | "formation of fibrous tissue within the heart often resulting from inflammation or injury " [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0003352 | increased circulating renin level | "elevated blood concentration of this enzyme which is secreted by the kidney; it cleaves a bond in angiotensionogen to generate angiotensin I " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, ncbi:Matthew Mailman, NCBI request] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0003620 | decreased urine output | "decreased volume of urine produced and excreted" [ncbi:Matthew Mailman, NCBI request] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0003638 | abnormal response/metabolism to endogenous compounds | "altered ability or inability to metabolize or respond to substances normally present in the body" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0003674 | oxidative stress | "condition characterized by an accumulation of free radical groups in the body, which creates a potentially unstable and damaging cellular environment linked to tissue damage, accelerated aging, and degenerative disease; can result from many factors, including exposure to alcohol, medications, poor nutrition, trauma, cold or toxins; may be indicated by low antioxidant levels measured in blood plasma" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0004119 | hypokalemia | "excessively low concentrations of potassium in the circulating blood; may be chronic or due to gastrointestinal and kidney depletion due to infection" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0004564 | enlarged myocardial fiber | "increased size of cardiac muscle fibers, the multinucleated muscle cells of the heart" [MGI:monikat "Monika Tomczuk, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0005319 | abnormal enzyme/ coenzyme level | "altered concentration of any of these proteins, or their cofactors, that act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0005582 | increased renin activity | "greater than the normal ability of this enzyme to cleave angiotensinogen and create angiotensin I" [RGD:Rat Genome Database submission, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0005584 | abnormal enzyme/coenzyme activity | "altered ability of any of these proteins, or their cofactors, to act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0005627 | increased circulating potassium level | "greater than the normal concentration in the blood of this alkaline metallic element, the most abundant intracellular ion; anomalies in the extracellular (circulating) concentration have important implications for the function of excitable tissues, such as nerve and muscle" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0008055 | increased urine osmolality | "increase in the concentration of ions in the urine compared to the normal state" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|
MP:0008288 | abnormal adrenal cortex morphology | "any structural anomaly of the thick outer layer of the adrenal gland that produces and secretes steroid hormones such as corticosterone, estrone and aldosterone" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition", MGI:llw2 "Linda Washburn, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0008291 | abnormal adrenocortical cell morphology | "any structural anomaly of the steroid hormone-producing cells of the cortex of the adrenal gland" [MGI:llw2 "Linda Washburn, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0008293 | abnormal zona glomerulosa morphology | "any structural anomaly of the narrow subcapsular outer zone of the adrenal cortex where aldosterone is produced" [MESH:A06.407.071.140.960, MGI:llw2 "Linda Washburn, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
Allelic Composition: Cyp11b2tm1.1(cre)Brlt/Cyp11b2+,Nr5a1tm2Klp/Nr5a1tm2Klp Genetic Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
|
MP:0011086 | partial postnatal lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms anytime between the neonatal period and weaning age (Mus: P1 to approximately 3 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Gabrg2tm2.1Geh/Gabrg2tm2.1Geh Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
|
MP:0011942 | decreased fluid intake | "reduction in the total amount of fluid taken in over time when compared to the normal state" [MGI:csmith] |
Show
Allelic Composition: Ptpn22tm2Achn/Ptpn22tm2Achn Genetic Background: B6.Cg-Ptpn22tm2Achn
|